AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oncopeptides

Major Shareholding Notification Jun 13, 2024

3091_iss_2024-06-13_c3d92464-67ff-43ed-87c6-ddc3d5165e80.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Oncopeptides AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Share loan
Date 11/06/2024
Limit for number of votes 5 %
After the transaction
Quantity
Shares 10,486,684
Directly held voting rights 0
Indirectly held voting rights 10,486,684
Percentage
Directly held shares 4.8733 %
Directly held voting rights 0 %
Indirectly held voting rights 4.9596 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.9596 % 10,486,684
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
Instruments - FITA Ch. 4, section 2, first
- Physically settled
- Cash settled
Total 4.9596 % 10,486,684
Chain
of
controlling
companies
Voting rights % Voting rights Company
10,179,989 4.81455
306,695
0.14504
Nordnet Pensionsförsäkring AB
Nordnet Livsforsikring AS
total
Group
holdings
Voting rights 10,486,684
Percentage of voting rights 4.9596
Published
13/06/2024 13:59
Contact
Name
Felix Mandoki
Phone +46766110734 Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.